Press Releases

GlobeNewswire, Inc.

Lasme-cel: Pivotal Phase 2 in r/r B-ALL (BALLI-01) FDA RMAT designation received for lasme-cel Full Phase 1 clinical data from the BALLI-01 trial presented at EHA 2026 Pivotal Phase 2 first interim analysis expected in Q4 2026 Eti-cel: Phase 1 in...

GlobeNewswire, Inc.

NDA submission for azetukalner on track for Q3 2026 following pre-NDA meeting with FDA Phase 3 X-TOLE3 study in FOS and X-ACKT study in PGTCS continue to enroll Three Phase 3 studies of azetukalner in neuropsychiatry continue to advance, with...

GlobeNewswire, Inc.

Company pivot to neuro-ophthalmology continues with Privosegtor positioned as lead late-stage asset through the registrational PIONEER program with expansion potential in acute multiple sclerosis (MS) relapses following positive FDA pre-IND...

GlobeNewswire, Inc.

-- Regulatory alignment with U.S. Food and Drug Administration (FDA) on key elements of NOV-ERA Phase 2b study design with Ontunisertib in Fibrostenosing Crohn’s Disease (FSCD), including Novel Primary Endpoint of Endoscopic Passability -- --...

GlobeNewswire, Inc.

DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) -- (https://247mnn.com/) – ClearOne (NASDAQ: CLRO), NeOnc Technologies (NASDAQ: NTHI), Iovance Biotherapeutics (NASDAQ:IOVA), and Ensysce Biosciences (NASDAQ:ENSC) are covered in today’s roundup.

GlobeNewswire, Inc.

BRISTOL, R.I., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Roger Williams University and Girl Scouts of Southeastern New England (GSSNE) have announced a first-of-its-kind partnership that streamlines the college admissions process for Girl Scouts across...

GlobeNewswire, Inc.

Immunocore reports second quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $115.9 million in Q2 2026, growing by 18% year-over-year Enrollment in Phase 3 TEBE-AM trial for previously treated...

GlobeNewswire, Inc.

TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus” or “the Company”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, announced today it acquired Valos (U.K.) Limited, an AI-powered platform...

EIN Presswire

Commercial Cleaning Services Sydney are evolving as businesses adopt advanced sanitisation, smarter cleaning practices and stronger workplace hygiene standards.

EIN Presswire

Chartered Institute of Professional Certifications Launches Certified UK Financial Reporting and Compliance Manager (CFR™) Program for Finance Professionals LONDON, UNITED KINGDOM, August 6, 2026 /⁨EINPresswire.com⁩/ -- The Chartered Institute of...

GlobeNewswire, Inc.

MIAMI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- OpenFX, the real-time cross-border money movement platform, announced today that it has acquired Global Ledger, founded by Tyler McIntyre.

GlobeNewswire, Inc.

HERZLIYA, Israel, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help customers scale their business by simplifying payments and maximizing loyalty, today...

GlobeNewswire, Inc.

Worldwide revenue of $388.2 million in the second quarter of 2026 GAAP fully diluted earnings per share of $1.11, compared to $1.12 in the second quarter of 2025 Adjusted fully diluted earnings per share of $1.55, compared to $1.57 in the second...

EIN Presswire

JustMarkets analysis highlights factors that may shape EUR/USD, GBP/USD and USD/JPY around the 15-16 September FOMC meeting.

GlobeNewswire, Inc.

Positive Phase 3 HAELO clinical data for lonvo-z in HAE presented at EAACI and published in New England Journal of Medicine Anticipate FDA acceptance of BLA for lonvo-z in second half of 2026 and U.S. launch in first half of 2027 Enrollment...

GlobeNewswire, Inc.

SINGAPORE, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) reports its unaudited financial and operating results for the three and six month periods ended 30 June 2026. The complete...

GlobeNewswire, Inc.

– On track for mid-2027 topline data readout from 80 patients in the Phase 2 ASPEN-09-Breast clinical trial evaluating evorpacept in combination with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer – – Presented encouraging...

GlobeNewswire, Inc.

LONDON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- DP World has reached an agreement with GXO Logistics (NYSE: GXO) for the transfer of six contract logistics sites serving grocery customers, with more than two million square feet of warehouse capacity and...

GlobeNewswire, Inc.

LONDON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Affinia, a RedBird Capital Partners (“RedBird”) portfolio company and the UK’s fastest-growing integrated accounting and advisory group, today announced that it has welcomed Wilson Partners, a...

GlobeNewswire, Inc.

-- IND and CTA clearances in the United States and New Zealand establish a global Phase 1/2 program for PM577a in Wilson disease; study startup activities underway, with initial clinical data in 2027 -- -- Favorable arbitration resolution with...